Metabolic syndrome resolution by Roux-en-Y gastric bypass in a real world: a case control study

Summary Objectives: the aim of this study was to evaluate the efficacy of Roux-en-Y Gastric Bypass (RYGB), compared with nonsurgical treatment (NS group), as an instrument for inducing remission of co-morbidities related to Metabolic Syndrome (MetS) in patients with Obesity, grades 2 and 3 (Ob2,3)....

Full description

Saved in:
Bibliographic Details
Published in:Revista da Associação Médica Brasileira (1992) 2015-03, Vol.61 (2), p.161-169
Main Authors: Schmid, Helena, Goelzer Neto, Claudio Fernando, Dias, Lisiane Stefani, Weston, Antonio Carlos, Espíndola, Marília Bittencourt, Pioner, Sergio Ricardo, Carli, Luiz Alberto De
Format: Magazinearticle
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objectives: the aim of this study was to evaluate the efficacy of Roux-en-Y Gastric Bypass (RYGB), compared with nonsurgical treatment (NS group), as an instrument for inducing remission of co-morbidities related to Metabolic Syndrome (MetS) in patients with Obesity, grades 2 and 3 (Ob2,3). Methods: two hundred and fifty eight Ob2,3 patients were selected in a retrospective analysis and included in a case control study. MetS was defined as described by the International Diabetes Federation. One hundred and twenty-nine of these patients underwent RYGB (S group), and 129 were assessed as an NS group. Results: at baseline, S and NS groups did not differ in BMI, age, female sex and prevalence of MetS (p>0.05). For the S group the outcomes were a reduction in BMI of 38.1% (p
ISSN:0104-4230
0104-4230
DOI:10.1590/1806-9282.61.02.161